Loading...
•
Oct 02, 2020
Danaher Q3 2020 Earnings Report
Danaher reported outstanding third quarter results, achieving double-digit revenue growth and over 60% adjusted EPS growth, while more than doubling their free cash flow year-over-year.
Key Takeaways
Danaher Corporation announced strong Q3 2020 results, with a 34.5% increase in revenues to $5.9 billion and a 62.0% increase in non-GAAP adjusted diluted net earnings per common share to $1.72. The company also saw a 93.0% increase in operating cash flow and a 110.0% increase in non-GAAP free cash flow.
Net earnings were $883.5 million, or $1.16 per diluted common share, a 38.0% year-over-year increase.
Non-GAAP adjusted diluted net earnings per common share were $1.72, a 62.0% increase year-over-year.
Revenues increased 34.5% year-over-year to $5.9 billion, with 14.0% non-GAAP core revenue growth including Cytiva.
Operating cash flow was $1.7 billion, a 93.0% increase year-over-year, and non-GAAP free cash flow was $1.5 billion, a 110.0% increase year-over-year.
Forward Guidance
For the fourth quarter 2020, the Company anticipates that non-GAAP core revenue growth including Cytiva will be in the low-double digit range.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...